Table 2. Intra- and Postoperative data for Patients With HCC and PVTTa.
| Variable | Value | P |
|---|---|---|
| LIHL, cm | 10.5 ± 3.0 (4.6 - 14.8) | |
| Operation time, h | 2.0 ± 0.6 (1.0 - 3.0) | |
| Radiography for PVTT | ||
| Time, s | 8 ± 2 (5 - 10) | |
| Pressure, bp | 247.1 ± 94.3 (100.0 - 350.0) | |
| Speed, mL/s | 1.6 ± 0.5 (1.0 - 2.0) | |
| LEM, mL | 7.5 ± 4.4 (2.0 - 17.0) | |
| Epirubicin, mg | 49.4 ± 7.5 (30.0 - 70.0) | |
| Operation sessions: 2; 3; 4 | 9 (52.9); 4 (23.5); 4 (23.5) | |
| Prothrombin time, s | 13.4 ± 2.0 (11.1 - 18.5) | |
| Thrombin time, s | 19.7 ± 1.6 (16.9 - 23.6) | |
| Albumin, g/d | 36.3 ± 10.2 (24.5 - 72.6) | 0.04 |
| Total bilirubin, µmol/L | 51.4 ± 61.2 (13.7 - 278.0) | 0.23 |
| ALT, µ/L | 308.0 ± 339.0 (43.0 - 1071.0)b | 0.02 |
| AST, µ/L | 370.4 ± 573.0 (37.0 - 1920.0)b | 0.08 |
| α-Fetoprotein, ng/mL | 471.1 ± 509.7 (6.9 - 1210)c,d | 0.81 |
| Follow-up (months) | 18.3 ± 9.0 (3.4 - 36.8) | |
| IAGI: 1; 2; 3 | 1 (5.9); 10 (58.8); 6 (35.3) | |
| IAGP: 1; 2; 3 | 6 (35.3); 8 (47.1); 3 (17.6) | |
| Outcome | ||
| Alive w/disease | 7 (50) | |
| Died of disease | 9 (52.9) | |
| Died of GI hemorrhage | 1 (5.9) |
Abbreviations: IAGP, iodized oil accumulation grade of PVTT; IAGI, iodized oil accumulation grade of intrahepatic lesions; LEM, lipiodol-ethanol mixture; LIHL, largest tumor size among intrahepatic lesions; ALT, alanine aminotransferase; AST, aspartate aminotransferase.
aData are expressed as mean ± standard deviation (range) for continuous variables of No. (%) for categorical variables; P values were determined by paired t test for preoperative vs. postoperative values.
bData for patient 11 or patients 14 and 17, respectively, were lost; statistical data were determined for 16 or 15 patients, respectively.
cValues exceeding the maximum value of 1210 ng/mL were counted as 1210 ng/mL in the statistics.
dData for patient 11 or patients 14 and 17, respectively, were lost; statistical data were determined for 16 or 15 patients, respectively.